Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine- induced cerebrovascular hyperperfusion in adult male wistar rats

Journal of Neuroscience Research

Volumn 88, Issue 7, 2010, Pages 1557-1568

  Van Donkelaar, Eva L ^a,c   Kelly, Paul A T ^b   Dawson, Neil ^b   Blokland, Arjan ^a,c   Prickaerts, Jos ^a,c   Steinbusch, Harry W M ^a,c   Ferrington, Linda ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c European Graduate School of Neuroscience   (Netherlands)

Author keywords

Cerebrovascular dysfunction; Ecstacy; Flow metabolism coupling; Plasma tryptophan; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DEOXYGLUCOSE C 14; IODOPHENAZONE C 14; PAROXETINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN REGION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEPLETION; DEPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRYPTOPHAN BRAIN LEVEL;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HYPEREMIA; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PAROXETINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN; VASODILATION;

EID: 77952067388     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22308     Document Type: Article

References (69)

1. Ando RD, Benko A, Ferrington L, Kirilly E, Kelly PA, Bagdy G. 2006. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 50:884-896. (Pubitemid 43750302)
2. Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G. 2004. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drugnaive rats and rats previously exposed to MDMA. Psychopharmacology 173:296-309. (Pubitemid 38703803)
3. 3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916.
4. Baumann MH, Wang X, Rothman RB. 2007. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189:407-424. (Pubitemid 44791212)
5. Bel N, Artigas F. 1996. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. J Neurochem 67:669-676. (Pubitemid 26255663)
6. Bell CJ, Hood SD, Nutt DJ. 2005. Acute tryptophan depletion. Part II: clinical effects and implications. Aust N Z J Psychiatry 39:565-574.
7. Blasberg RG, Fenstermacher JD, Patlak CS. 1983. Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 3:8-32.
8. Boadle-Biber MC. 1993. Regulation of serotonin synthesis. Prog Biophys Mol Biol 60:1-15.
9. Booij L, Van der Does W, Benkelfat C, Bremner JD, Cowen PJ, Fava M, Gillin C, Leyton M, Moore P, Smith KA, Van der Kloot WA. 2002. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 27:852-861. (Pubitemid 35335901)
10. Booij L, van der Does AJ, Haffmans PM, Spinhoven P, McNally RJ. 2005. Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations. Br J Psychiatry 187:148-154. (Pubitemid 41139687)
11. Cahir M, Ardis T, Reynolds GP, Cooper SJ. 2007. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat. Psychopharmacology 190:497-506. (Pubitemid 46204467)
12. Callahan BT, Cord BJ, Ricaurte GA. 2001. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse 40:113-121.
13. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389. (Pubitemid 36877077)
14. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. 1987. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338-345. (Pubitemid 17119380)
15. Curran HV, Verheyden SL. 2003. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology 169:91-103.
16. Darvesh AS, Shankaran M, Gudelsky GA. 2002. 3,4- Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther 301:138-144. (Pubitemid 34250289)
17. 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1:488-496.
18. Dixon WJ. 1959. Analysis of extreme values. Ann Math Stat 21:488-506.
19. Domek-Lopacinska K, Strosznajder JB. 2008. The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. Brain Res 1216:68-77.
20. Dunn RT, Willis MW, Benson BE, Repella JD, Kimbrell TA, Ketter TA, Speer AM, Osuch EA, Post RM. 2005. Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Res 140:181-198.
21. Fadda F. 2000. Tryptophan-free diets: a physiological tool to study brain serotonin function. News Physiol Sci 15:260-264.
22. Fadda F, Cocco S, Rossetti ZL, Melis G, Stancampiano R. 2000a. A tryptophan-free diet markedly reduces frontocortical 5-HT release, but fails to modify ethanol preference in alcohol-preferring (sP) and nonpreferring (sNP) rats. Behav Brain Res 108:127-132. (Pubitemid 30084829)
23. Fadda F, Cocco S, Stancampiano R. 2000b. A physiological method to selectively decrease brain serotonin release. Brain Res Brain Res Protoc 5:219-222. (Pubitemid 30440749)
24. Fernstrom JD. 1979. Diet-induced changes in plasma amino acid pattern: effects on the brain uptake of large neutral amino acids, and on brain serotonin synthesis. J Neural Transm Suppl, p 55-67.
25. Fernstrom JD. 1983. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63:484-546.
26. Fernstrom JD. 1986. Acute and chronic effects of protein and carbohydrate ingestion on brain tryptophan levels and serotonin synthesis. Nutr Rev 44(Suppl):25-36.
27. Fernstrom JD, Wurtman RJ. 1972. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178:414-416.
28. Ferrington L, Kirilly E, McBean DE, Olverman HJ, Bagdy G, Kelly PA. 2006. Persistent cerebrovascular effects of MDMA and acute responses to the drug. Eur J Neurosci 24:509-519. (Pubitemid 44100342)
29. Ford I, McColl JH, McCormack AG, McCrory SJ. 1991. Statistical issues in the analysis of neuroimages. J Cereb Blood Flow Metab 11:A89-A95.
30. Geiser S, Greenhouse SW. 1958. Box's results on the use of the F distribution in multivariate analysis. Ann Math Statist 29:885-891.
31. Green AR, Mechan AO, Elliott JM, O'shea E, Colado MI. 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508.
32. Guillot C. 2007. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? J Psychoactive Drugs 39:31-39.
33. Hood SD, Bell CJ, Nutt DJ. 2005. Acute tryptophan depletion. Part I: rationale and methodology. Aust N Z J Psychiatry 39:558-564. (Pubitemid 41602540)
34. Jans LA, Blokland A. 2008. Influence of chronic mild stress on the behavioural effects of acute tryptophan depletion induced by a gelatinbased mixture. Behav Pharmacol 19:706-715.
35. Jans LA, Lieben CK, Blokland A. 2007. Influence of sex and estrous cycle on the effects of acute tryptophan depletion induced by a gelatinbased mixture in adult Wistar rats. Neuroscience 147:304-317. (Pubitemid 46907457)
36. Jans L, Korte-Bouws G, Korte S, Blokland A. 2008a. The effects of acute tryptophan depletion on affective behaviour and cognition in brown Norway and Sprague Dawley rats. J Psychopharmacol (in press).
37. Jans LA, Lieben CK, Smits LT, Blokland A. 2008b. Pharmacokinetics of acute tryptophan depletion using a gelatin-based protein in male and female Wistar rats. Amino Acids (in press).
38. Jennrich R, Sampson P, Frane J. 1990. Analysis of variance and covariance with repeated measures. In: Dixon WJ, Brown MB, Engelman L, Jenrich RI, editors. BMDP statistical software manual, vol 1. Berkeley, CA: University of California Press. p 486-527.
39. Kelly PA, Ritchie IM, Arbuthnott GW. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: effects upon local cerebral blood flow and glucose use in the rat. J Cereb Blood Flow Metab 15:766-773.
40. Leonardi ET, Azmitia EC. 1994. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10:231-238.
41. Lieben CK, Blokland A, Westerink B, Deutz NE. 2004a. Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein-carbohydrate mixture in the adult rat. Neurochem Int 44:9-16. (Pubitemid 37101139)
42. Lieben CK, van Oorsouw K, Deutz NE, Blokland A. 2004b. Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behav Brain Res 151:53-64. (Pubitemid 38501428)
43. Markus CR, Panhuysen G, Tuiten A, Koppeschaar H, Fekkes D, Peters ML. 1998. Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 31:49-65.
44. McCulloch J, Kelly PA, Ford I. 1982. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab 2:487-499. (Pubitemid 13168827)
45. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, Gillin JC. 2000. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601-622.
46. Moreno FA, Heninger GR, McGahuey CA, Delgado PL. 2000. Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol Psychiatry 48:327-329.
47. Neumeister A. 2003. Tryptophan depletion, serotonin, and depression: where do we stand? Psychopharmacol Bull 37:99-115.
48. Nichols DE, Oberlender R. 1990. Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs? Ann N Y Acad Sci 600:613-623; discussion 623-625.
49. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME. 1988. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803.
50. Olivier JD, Jans LA, Korte-Bouws GA, Korte SM, Deen PM, Cools AR, Ellenbroek BA, Blokland A. 2008. Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology 200:243-254.
51. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed, vol 4. San Diego: Elsevier Academic Press.
52. Quate L, McBean DE, Ritchie IM, Olverman HJ, Kelly PA. 2004. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat. Psychopharmacology 173:287-925. (Pubitemid 38703802)
53. Rapport MM, Green AA, Page IH. 1948. Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem 176:1243-1251.
54. Ricaurte GA, Yuan J, McCann UD. 2000. (±)3,4- Methylenedioxymethamphetamine ("ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10. (Pubitemid 30436310)
55. Rutten K, Lieben C, Smits L, Blokland A. 2007. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology 192:275-282. (Pubitemid 46669202)
56. 14C]antipyrine. Am J Physiol 234:H59-H66.
57. Sharkey J, McBean DE, Kelly PA. 1991. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("ecstasy"). Psychopharmacology 105:113-118.
58. Sokoloff L. 1981. The deoxyglucose method for the measurement of local glucose utilization and the mapping of local functional activity in the central nervous system. Int Rev Neurobiol 22:287-333.
59. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916.
60. Stancampiano R, Melis F, Sarais L, Cocco S, Cugusi C, Fadda F. 1997. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am J Physiol 272:R991-R994. (Pubitemid 27146811)
61. Stone DM, Merchant KM, Hanson GR, Gibb JW. 1987. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26:1677-1683. (Pubitemid 18007648)
62. Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH. 2002. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 27:993-1005. (Pubitemid 35447636)
63. Taffe MA, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH. 2003. MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol Biochem Behav 76:141-152. (Pubitemid 38366177)
64. Trulson ME. 1985. Dietary tryptophan does not alter the function of brain serotonin neurons. Life Sci 37:1067-1072.
65. Van der Does AJ. 2001. The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings. Arch Gen Psychiatry 58:200-202.
66. van der Plasse G, Meerkerk DT, Lieben CK, Blokland A, Feenstra MG. 2007. Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion. Psychopharmacology 195:377-385. (Pubitemid 350160272)
67. van Donkelaar EL, Rutten K, Blokland A, Akkerman S, Steinbusch HW, Prickaerts J. 2008. Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion. Eur J Pharmacol 600:98-104.
68. van Eijk HM, Rooyakkers DR, Deutz NE. 1993. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr 620:143-148.
69. Walther DJ, Bader M. 2003. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66:1673-1680. (Pubitemid 37249312)